Assessment of antibodies in the upper and lower human respiratory tract at steady state and after respiratory viral infection
Clinical & Translational Immunology · 2023-01 · 12 (8)
DOI: 10.1002/cti2.1460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Translational Immunology, online erschienen am 08.08.2023. Verfasst von Marios Koutsakos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology The University of Melbourne at the Peter Doherty Institute for Infection and Immunity Melbourne VIC Austral…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, Emergency Medicine Foundation.
Abstract (Originalsprache)
Objectives
There is an increasing appreciation for the need to study mucosal antibody responses in humans. Our aim was to determine the utility of different types of samples from the human respiratory tract, specifically nasopharyngeal (NP) swabs obtained for diagnostic purposes and bronchoalveolar lavage (BAL) obtained in outpatient and inpatient settings.
Methods
We analysed antibody levels in plasma and NP swabs from 67 individuals with acute influenza as well as plasma and BAL from individuals undergoing bronchoscopy, including five control subjects as well as seven moderately and seven severely ill subjects with a respiratory viral infection. Levels of α2‐macroglobulin were determined in BAL and plasma to assess plasma exudation.
Results
IgG and IgA were readily detectable in BAL and NP swabs, albeit at different ratios, while IgM levels were low. The total amount of antibody recovered from NP swabs varied greatly between study participants. Accordingly, the levels of influenza HA‐specific antibodies varied, and individuals with lower amounts of total Ig in NP swabs had undetectable levels of HA‐specific Ig. Similarly, the total amount of antibody recovered from BAL varied between study participants. However, severely ill patients showed evidence of increased plasma exudation, which may confound analysis of their BAL samples for mucosal antibodies.
Conclusion
Nasopharyngeal swabs collected for diagnostic purposes may have utility in assessing antibodies from the human nasal mucosa, but variability in sampling should be accounted for. BAL samples can be utilised to study antibodies from the lower respiratory tract, but the possibility of plasma exudation should be excluded.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology The University of Melbourne at the Peter Doherty Institute for Infection and Immunity Melbourne VIC Australia.
- Department of Pathology and Immunology Washington University School of Medicine Saint Louis MO USA.
- Division of Pulmonology and Critical Care, Department of Medicine Washington University School of Medicine Saint Louis MO USA.
- Division of Infectious Diseases, Department of Medicine Washington University School of Medicine Saint Louis MO USA.
- Center for Vaccines and Immunity to Microbial Pathogens Washington University School of Medicine Saint Louis MO USA.
- The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs Washington University School of Medicine Saint Louis MO USA.
ORCID-Profile: Marios Koutsakos
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- Emergency Medicine Foundation
- Morningside Foundation
- National Health and Medical Research Council
- National Institutes of Health
- State Government of Victoria
Zitieren
APA
Koutsakos, M., Turner, J. S., Guillamet, M. C. V., Reynolds, D., Lei, T., Byers, D. E., Ellebedy, A. H., & Mudd, P. A. (2023). Assessment of antibodies in the upper and lower human respiratory tract at steady state and after respiratory viral infection. Clinical & Translational Immunology, 12(8). https://doi.org/10.1002/cti2.1460
Vancouver
Koutsakos M, Turner JS, Guillamet MCV, Reynolds D, Lei T, Byers DE, et al. Assessment of antibodies in the upper and lower human respiratory tract at steady state and after respiratory viral infection. Clinical & Translational Immunology. 2023;12(8). doi:10.1002/cti2.1460
BibTeX
@article{Koutsakos2023,
author = {Koutsakos, Marios and Turner, Jackson S and Guillamet, M Cristina Vazquez and Reynolds, Daniel and Lei, Tingting and Byers, Derek E and Ellebedy, Ali H and Mudd, Philip A},
title = {Assessment of antibodies in the upper and lower human respiratory tract at steady state and after respiratory viral infection},
journal = {Clinical & Translational Immunology},
year = {2023},
volume = {12},
number = {8},
doi = {10.1002/cti2.1460}
}
EUVIMED